Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Liposome encapsulated prednisolone

Drug Profile

Liposome encapsulated prednisolone

Alternative Names: GLPG-0303; Liposomal prednisolone; Nanocort; PEG-liposomal prednisolone sodium phosphate

Latest Information Update: 05 Oct 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Enceladus Pharmaceuticals
  • Developer Enceladus Pharmaceuticals; Galapagos NV; Leiden University Medical Center; Sun Pharmaceutical Industries
  • Class Anti-inflammatories; Antiallergics; Antineoplastics; Antirheumatics; Corticosteroids; Glucocorticoids; Pregnadienetriols; Small molecules
  • Mechanism of Action Arachidonic acid inhibitors; Glucagon receptor agonists; Glucocorticoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Rheumatoid arthritis
  • Phase II Arteriovenous fistula; Graves ophthalmopathy; Ulcerative colitis
  • Suspended Multiple sclerosis

Most Recent Events

  • 24 Jun 2018 Biomarkers information updated
  • 20 Jul 2017 Phase-II clinical trials in Graves ophthalmopathy in Netherlands (IV) (EudraCT2017-001158-33)
  • 16 Mar 2016 Efficacy and adverse events data from a phase II trial in Ulcerative colitis released by Enceladus Pharmaceuticals
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top